merger

Showing 15 posts of 69 posts found.

Pfizer image

Pfizer grilled by MPs – but AZ revelations shock

May 14, 2014
Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover

The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …

Allergan image

Valeant ‘substantially undervalues’ Allergan

May 13, 2014
Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger

Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …

Ian Read image

Poll: UK opposed to Pfizer takeover bid of AZ

May 13, 2014
Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research

The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014
Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

Bayer concludes $14bn Merck consumer care takeover

May 7, 2014
Sales and Marketing Bayer, Merck, OTC, consumer care, merger

 Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …

Pfizer will ‘suck AZ’s lifeblood’

May 7, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, bbd, cable, merger

A former boss of AstraZeneca has warned that he fears Pfizer “will act like a praying mantis and suck the …

Cameron image

Pfizer appeals to UK prime minister

May 6, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, Cameron, Pfizer, merger, research

Pfizer has attempted to enlist the help of UK prime minister David Cameron in its campaign to buy AstraZeneca, offering …

chairman Leif Johansson image

AZ video: ‘Why we rejected Pfizer offer’

May 2, 2014
Medical Communications, Sales and Marketing AstraZeneca, Pfizer, UK, buyout, merger, research

AstraZeneca has confirmed that it is not for turning when it comes to buyout offers from Pfizer and is happy …

Pfizer image

Pfizer/AZ deal would put UK research in jeopardy

May 1, 2014
Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research

The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …

Merck image

Merck’s Q1 sales drop

April 30, 2014
Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales

Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …

Pfizer image

Pfizer ‘significantly undervalued’ AstraZeneca

April 29, 2014
Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger

AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …

Pfizer makes second bid for AstraZeneca

April 28, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, acquisition, deal, merger

Pfizer has made a second attempt to buy AstraZeneca after an initial request was rejected in January. The biggest pharma …

Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

GSK and Novartis sign multi-billion dollar deal

April 23, 2014
Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines

GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …

AstraZeneca image

AstraZeneca ‘rejects Pfizer bid’

April 22, 2014
Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger

AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …

Latest content